Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$849,257.85
% of Total Estimate Gain
6.00%

Goldman Sachs Small Cap Equity Insights Fund's Halozyme Therapeutics Inc Holding Summary

As of 2025-04-30, GOLDMAN SACHS TRUST held - shares of Halozyme Therapeutics Inc(HALO), totaling N/A. This investment constitutes 0% of their stock portfolio, and GOLDMAN SACHS TRUST now holds 0% of the outstanding Halozyme Therapeutics Inc(HALO) stock.

The initial trade took place in 2019Q4. And since then Goldman Sachs Small Cap Equity Insights Fund has made 8 purchases of HALO, at an average price of $29.41, for a total of 481,597.00 shares. In addition, there have been 8 sales at an average price of $31.17 for 481,597.00 shares. Based on historical transaction data and HALO's current price of $56.45, Goldman Sachs Small Cap Equity Insights Fund's estimated gain on his HALO holdings is $849,257.85, reflecting a 6.00% gain to date.

Goldman Sachs Small Cap Equity Insights Fund HALO ($56.45) Holding Chart

Goldman Sachs Small Cap Equity Insights Fund HALO ($56.45) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1